Sarah Elizabeth Little, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cesarean Section | 28 | 2023 | 1396 | 4.200 |
Why?
|
Labor, Induced | 9 | 2023 | 151 | 2.520 |
Why?
|
Obstetric Labor Complications | 6 | 2022 | 236 | 1.980 |
Why?
|
Delivery, Obstetric | 16 | 2024 | 940 | 1.810 |
Why?
|
Gestational Age | 24 | 2024 | 3577 | 1.690 |
Why?
|
Stillbirth | 5 | 2023 | 368 | 1.600 |
Why?
|
Puerperal Disorders | 5 | 2024 | 299 | 1.540 |
Why?
|
Parity | 9 | 2022 | 927 | 1.500 |
Why?
|
Term Birth | 4 | 2021 | 138 | 1.460 |
Why?
|
Pregnancy | 75 | 2024 | 29874 | 1.380 |
Why?
|
Premature Birth | 11 | 2023 | 1782 | 1.270 |
Why?
|
Labor, Obstetric | 3 | 2023 | 323 | 1.260 |
Why?
|
Vaginal Birth after Cesarean | 3 | 2018 | 61 | 1.240 |
Why?
|
Labor Stage, Second | 3 | 2022 | 38 | 1.120 |
Why?
|
Trial of Labor | 5 | 2022 | 81 | 1.040 |
Why?
|
Ultrasonography, Prenatal | 8 | 2023 | 1755 | 1.040 |
Why?
|
Umbilical Arteries | 1 | 2023 | 79 | 0.840 |
Why?
|
Pregnancy in Diabetics | 2 | 2021 | 197 | 0.820 |
Why?
|
Abortion, Induced | 3 | 2017 | 462 | 0.800 |
Why?
|
Pregnancy, High-Risk | 2 | 2020 | 122 | 0.800 |
Why?
|
Eclampsia | 1 | 2022 | 56 | 0.790 |
Why?
|
Hypertension, Pregnancy-Induced | 3 | 2024 | 518 | 0.780 |
Why?
|
Postpartum Period | 9 | 2024 | 1173 | 0.740 |
Why?
|
Fetal Growth Retardation | 2 | 2023 | 580 | 0.730 |
Why?
|
Ultrasonography, Doppler | 1 | 2023 | 462 | 0.730 |
Why?
|
Oxytocics | 1 | 2021 | 67 | 0.720 |
Why?
|
Perineum | 2 | 2018 | 208 | 0.700 |
Why?
|
Progesterone | 1 | 2023 | 742 | 0.660 |
Why?
|
Labor Stage, First | 1 | 2019 | 20 | 0.650 |
Why?
|
Labor Onset | 1 | 2019 | 17 | 0.650 |
Why?
|
Pregnancy Outcome | 14 | 2024 | 2921 | 0.640 |
Why?
|
Watchful Waiting | 1 | 2023 | 491 | 0.620 |
Why?
|
Hospitals | 8 | 2021 | 3882 | 0.620 |
Why?
|
Chorioamnionitis | 1 | 2018 | 156 | 0.580 |
Why?
|
Diabetes, Gestational | 3 | 2023 | 1248 | 0.570 |
Why?
|
Surgical Wound Dehiscence | 1 | 2018 | 213 | 0.570 |
Why?
|
Aneuploidy | 3 | 2017 | 551 | 0.570 |
Why?
|
Lacerations | 1 | 2018 | 147 | 0.560 |
Why?
|
Oxytocin | 1 | 2021 | 402 | 0.550 |
Why?
|
Risk Adjustment | 2 | 2017 | 600 | 0.540 |
Why?
|
Pregnancy Trimester, Third | 1 | 2019 | 583 | 0.530 |
Why?
|
Abdominal Pain | 1 | 2022 | 1071 | 0.530 |
Why?
|
Patient Readmission | 6 | 2024 | 3270 | 0.520 |
Why?
|
Catheterization | 1 | 2021 | 1428 | 0.510 |
Why?
|
Fever | 2 | 2022 | 1618 | 0.500 |
Why?
|
Cost-Benefit Analysis | 10 | 2023 | 5492 | 0.500 |
Why?
|
Infant, Newborn | 24 | 2023 | 26198 | 0.490 |
Why?
|
Pregnancy Complications | 7 | 2024 | 2947 | 0.480 |
Why?
|
Maternal Age | 3 | 2020 | 809 | 0.460 |
Why?
|
Female | 84 | 2024 | 392644 | 0.440 |
Why?
|
Obstetrics | 3 | 2023 | 665 | 0.440 |
Why?
|
Birth Weight | 7 | 2023 | 2103 | 0.420 |
Why?
|
Placenta Previa | 4 | 2017 | 122 | 0.420 |
Why?
|
Pregnancy Trimester, Second | 1 | 2015 | 731 | 0.420 |
Why?
|
Fetal Weight | 1 | 2012 | 87 | 0.400 |
Why?
|
Retrospective Studies | 36 | 2024 | 80636 | 0.400 |
Why?
|
Decision Support Techniques | 7 | 2017 | 1998 | 0.390 |
Why?
|
Pre-Eclampsia | 5 | 2023 | 1231 | 0.380 |
Why?
|
Health Services Research | 1 | 2018 | 1812 | 0.360 |
Why?
|
Cervical Ripening | 2 | 2021 | 18 | 0.350 |
Why?
|
Logistic Models | 11 | 2022 | 13255 | 0.350 |
Why?
|
Adult | 51 | 2024 | 221177 | 0.340 |
Why?
|
Hysterectomy | 6 | 2022 | 857 | 0.340 |
Why?
|
Growth Charts | 2 | 2020 | 60 | 0.330 |
Why?
|
Maternal Health Services | 3 | 2020 | 461 | 0.330 |
Why?
|
Postnatal Care | 5 | 2024 | 262 | 0.320 |
Why?
|
Uterine Rupture | 2 | 2021 | 65 | 0.320 |
Why?
|
Prenatal Diagnosis | 4 | 2016 | 1265 | 0.320 |
Why?
|
Herpes Genitalis | 2 | 2011 | 150 | 0.320 |
Why?
|
Humans | 88 | 2024 | 761504 | 0.320 |
Why?
|
Placenta Accreta | 4 | 2017 | 237 | 0.310 |
Why?
|
Spinal Muscular Atrophies of Childhood | 1 | 2010 | 115 | 0.310 |
Why?
|
Workload | 1 | 2014 | 844 | 0.310 |
Why?
|
Pandemics | 4 | 2024 | 8654 | 0.300 |
Why?
|
Postpartum Hemorrhage | 2 | 2022 | 271 | 0.260 |
Why?
|
Pregnancy Rate | 2 | 2023 | 648 | 0.260 |
Why?
|
Fertilization in Vitro | 3 | 2023 | 1292 | 0.260 |
Why?
|
United States | 23 | 2022 | 72334 | 0.250 |
Why?
|
Acyclovir | 1 | 2005 | 268 | 0.240 |
Why?
|
Fetal Development | 2 | 2020 | 769 | 0.230 |
Why?
|
Administration, Intravaginal | 1 | 2023 | 150 | 0.220 |
Why?
|
Prenatal Care | 7 | 2020 | 1139 | 0.220 |
Why?
|
Boston | 4 | 2021 | 9326 | 0.210 |
Why?
|
Embryo Transfer | 1 | 2006 | 522 | 0.200 |
Why?
|
Research Design | 1 | 2018 | 6180 | 0.200 |
Why?
|
Genetic Testing | 3 | 2016 | 3537 | 0.200 |
Why?
|
Progestins | 1 | 2023 | 301 | 0.190 |
Why?
|
Hysterotomy | 1 | 2021 | 23 | 0.190 |
Why?
|
Labor Presentation | 2 | 2018 | 55 | 0.180 |
Why?
|
Biomedical Technology | 1 | 2003 | 211 | 0.180 |
Why?
|
Pregnancy Trimester, First | 2 | 2016 | 907 | 0.180 |
Why?
|
Young Adult | 17 | 2022 | 59243 | 0.180 |
Why?
|
Weightlessness | 1 | 2021 | 102 | 0.180 |
Why?
|
Patient Selection | 3 | 2017 | 4244 | 0.180 |
Why?
|
Multivariate Analysis | 4 | 2018 | 12059 | 0.170 |
Why?
|
Insurance, Health | 3 | 2020 | 2498 | 0.170 |
Why?
|
Regional Health Planning | 1 | 2019 | 96 | 0.160 |
Why?
|
Episiotomy | 1 | 2018 | 20 | 0.160 |
Why?
|
Cervix Uteri | 1 | 2023 | 570 | 0.160 |
Why?
|
Cataract Extraction | 1 | 2003 | 467 | 0.160 |
Why?
|
Extraction, Obstetrical | 1 | 2018 | 27 | 0.160 |
Why?
|
Infant, Newborn, Diseases | 3 | 2014 | 589 | 0.160 |
Why?
|
Abortion, Spontaneous | 1 | 2023 | 533 | 0.150 |
Why?
|
Down Syndrome | 2 | 2017 | 901 | 0.150 |
Why?
|
Risk Assessment | 6 | 2023 | 23995 | 0.150 |
Why?
|
Muscular Atrophy | 1 | 2021 | 334 | 0.150 |
Why?
|
Healthcare Disparities | 3 | 2020 | 3358 | 0.150 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2011 | 2151 | 0.150 |
Why?
|
Catheters | 1 | 2021 | 427 | 0.150 |
Why?
|
Hydrocephalus | 1 | 2024 | 764 | 0.150 |
Why?
|
Infant, Small for Gestational Age | 3 | 2020 | 461 | 0.150 |
Why?
|
Medically Uninsured | 1 | 2003 | 836 | 0.150 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2021 | 542 | 0.150 |
Why?
|
Estrogen Antagonists | 1 | 2018 | 150 | 0.140 |
Why?
|
Morbidity | 5 | 2021 | 1750 | 0.140 |
Why?
|
Quality-Adjusted Life Years | 5 | 2014 | 1722 | 0.140 |
Why?
|
Risk Factors | 15 | 2022 | 74206 | 0.140 |
Why?
|
Fetal Death | 2 | 2015 | 435 | 0.140 |
Why?
|
Cordocentesis | 1 | 2016 | 10 | 0.130 |
Why?
|
Narcotics | 1 | 2018 | 336 | 0.130 |
Why?
|
Military Personnel | 4 | 2020 | 1246 | 0.130 |
Why?
|
Predictive Value of Tests | 5 | 2023 | 15266 | 0.130 |
Why?
|
Uterine Hemorrhage | 1 | 2018 | 240 | 0.130 |
Why?
|
Tracheostomy | 1 | 2020 | 426 | 0.130 |
Why?
|
Time Factors | 6 | 2021 | 39967 | 0.130 |
Why?
|
Health Care Costs | 2 | 2006 | 3242 | 0.130 |
Why?
|
Home Childbirth | 1 | 2015 | 55 | 0.120 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 2 | 2011 | 380 | 0.120 |
Why?
|
Pregnancy, Ectopic | 1 | 2016 | 142 | 0.120 |
Why?
|
Proportional Hazards Models | 2 | 2021 | 12463 | 0.120 |
Why?
|
Odds Ratio | 3 | 2017 | 9646 | 0.120 |
Why?
|
ROC Curve | 1 | 2023 | 3579 | 0.120 |
Why?
|
Placenta | 2 | 2021 | 1709 | 0.120 |
Why?
|
Trisomy | 1 | 2016 | 260 | 0.120 |
Why?
|
Cholestasis, Intrahepatic | 1 | 2014 | 75 | 0.120 |
Why?
|
Fetal Membranes, Premature Rupture | 1 | 2015 | 137 | 0.120 |
Why?
|
Comorbidity | 3 | 2018 | 10508 | 0.120 |
Why?
|
Patient Care Management | 1 | 2017 | 302 | 0.120 |
Why?
|
Birth Injuries | 1 | 2016 | 151 | 0.120 |
Why?
|
Genital Neoplasms, Female | 2 | 2011 | 532 | 0.120 |
Why?
|
Pregnancy in Adolescence | 1 | 2016 | 163 | 0.110 |
Why?
|
Chromosome Aberrations | 2 | 2018 | 1768 | 0.110 |
Why?
|
Brachial Plexus | 1 | 2016 | 167 | 0.110 |
Why?
|
Karyotyping | 1 | 2016 | 1171 | 0.110 |
Why?
|
Pregnancy Proteins | 1 | 2015 | 222 | 0.110 |
Why?
|
Chorionic Gonadotropin, beta Subunit, Human | 1 | 2014 | 81 | 0.110 |
Why?
|
Genetic Counseling | 2 | 2016 | 627 | 0.110 |
Why?
|
Diphtheria-Tetanus-acellular Pertussis Vaccines | 1 | 2014 | 38 | 0.110 |
Why?
|
Cohort Studies | 10 | 2021 | 41487 | 0.110 |
Why?
|
Ampicillin | 1 | 2013 | 136 | 0.110 |
Why?
|
Pregnancy-Associated Plasma Protein-A | 1 | 2014 | 60 | 0.110 |
Why?
|
Stress, Physiological | 1 | 2021 | 1403 | 0.110 |
Why?
|
Qualitative Research | 1 | 2024 | 3023 | 0.110 |
Why?
|
Cefazolin | 1 | 2013 | 94 | 0.110 |
Why?
|
Parturition | 1 | 2017 | 445 | 0.110 |
Why?
|
Chromosome Disorders | 1 | 2016 | 497 | 0.110 |
Why?
|
Commerce | 1 | 2018 | 606 | 0.100 |
Why?
|
Monte Carlo Method | 3 | 2010 | 1258 | 0.100 |
Why?
|
Fee-for-Service Plans | 1 | 2017 | 700 | 0.100 |
Why?
|
DNA | 2 | 2016 | 7212 | 0.100 |
Why?
|
Unnecessary Procedures | 1 | 2015 | 415 | 0.100 |
Why?
|
Fetal Diseases | 1 | 2017 | 913 | 0.100 |
Why?
|
Head | 1 | 2017 | 924 | 0.100 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2015 | 558 | 0.100 |
Why?
|
Appointments and Schedules | 1 | 2015 | 443 | 0.100 |
Why?
|
Quality of Health Care | 2 | 2018 | 4330 | 0.090 |
Why?
|
International Classification of Diseases | 1 | 2017 | 909 | 0.090 |
Why?
|
Malpractice | 1 | 2015 | 556 | 0.090 |
Why?
|
Linear Models | 2 | 2017 | 5871 | 0.090 |
Why?
|
Depressive Disorder | 1 | 2003 | 3728 | 0.090 |
Why?
|
Choice Behavior | 1 | 2016 | 824 | 0.090 |
Why?
|
Survival of Motor Neuron 1 Protein | 1 | 2010 | 64 | 0.090 |
Why?
|
Program Evaluation | 1 | 2018 | 2495 | 0.080 |
Why?
|
Cross-Sectional Studies | 4 | 2023 | 26125 | 0.080 |
Why?
|
Combined Modality Therapy | 1 | 2021 | 8529 | 0.080 |
Why?
|
Desipramine | 2 | 1986 | 182 | 0.080 |
Why?
|
Confidence Intervals | 1 | 2014 | 2927 | 0.080 |
Why?
|
Databases, Factual | 4 | 2019 | 7967 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6484 | 0.080 |
Why?
|
Laparoscopy | 2 | 2017 | 2035 | 0.080 |
Why?
|
Maternal Mortality | 1 | 2011 | 302 | 0.080 |
Why?
|
Herpes Simplex | 1 | 2011 | 478 | 0.080 |
Why?
|
Alleles | 1 | 2019 | 6863 | 0.070 |
Why?
|
Neovascularization, Physiologic | 1 | 2015 | 1349 | 0.070 |
Why?
|
Health Services Accessibility | 2 | 2017 | 5440 | 0.070 |
Why?
|
Kenya | 2 | 2020 | 758 | 0.070 |
Why?
|
Multiple Birth Offspring | 1 | 2006 | 22 | 0.070 |
Why?
|
Prevalence | 1 | 2024 | 15732 | 0.070 |
Why?
|
Women's Health | 1 | 2016 | 2065 | 0.070 |
Why?
|
Myocardial Infarction | 2 | 2008 | 11460 | 0.070 |
Why?
|
Contraception | 1 | 2010 | 349 | 0.070 |
Why?
|
Socioeconomic Factors | 2 | 2018 | 7827 | 0.070 |
Why?
|
Coronary Circulation | 4 | 2008 | 1569 | 0.070 |
Why?
|
Body Mass Index | 2 | 2023 | 12953 | 0.070 |
Why?
|
Insulin | 1 | 2021 | 6596 | 0.070 |
Why?
|
Florida | 2 | 2018 | 431 | 0.060 |
Why?
|
Pregnancy, Multiple | 1 | 2006 | 215 | 0.060 |
Why?
|
Sexually Transmitted Diseases | 1 | 2011 | 662 | 0.060 |
Why?
|
Ovariectomy | 1 | 2007 | 614 | 0.060 |
Why?
|
New York | 2 | 2018 | 874 | 0.060 |
Why?
|
Gynecology | 2 | 2023 | 526 | 0.060 |
Why?
|
Middle Aged | 14 | 2021 | 220895 | 0.060 |
Why?
|
Hypertension | 2 | 2023 | 8540 | 0.060 |
Why?
|
Terminal Care | 1 | 2015 | 1760 | 0.060 |
Why?
|
Emigrants and Immigrants | 1 | 2010 | 543 | 0.050 |
Why?
|
Cerebrospinal Fluid Shunts | 1 | 2024 | 195 | 0.050 |
Why?
|
California | 2 | 2018 | 1429 | 0.050 |
Why?
|
Ion Channels | 1 | 2008 | 1040 | 0.050 |
Why?
|
Prospective Studies | 4 | 2021 | 54425 | 0.050 |
Why?
|
Quality Improvement | 1 | 2018 | 3801 | 0.050 |
Why?
|
Markov Chains | 1 | 2006 | 966 | 0.050 |
Why?
|
Adolescent | 7 | 2021 | 88319 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2016 | 3889 | 0.050 |
Why?
|
Exercise | 1 | 2019 | 5890 | 0.050 |
Why?
|
Oxygen Consumption | 2 | 2008 | 1866 | 0.050 |
Why?
|
Mitochondrial Proteins | 1 | 2008 | 976 | 0.050 |
Why?
|
Vaccination | 1 | 2014 | 3384 | 0.050 |
Why?
|
Cerebral Palsy | 1 | 2006 | 474 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2016 | 4016 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2019 | 5336 | 0.050 |
Why?
|
HSP72 Heat-Shock Proteins | 1 | 2021 | 40 | 0.050 |
Why?
|
Semen | 1 | 2023 | 347 | 0.050 |
Why?
|
Nitric Oxide Synthase Type I | 1 | 2021 | 174 | 0.040 |
Why?
|
Incidence | 2 | 2018 | 21353 | 0.040 |
Why?
|
London | 1 | 2020 | 234 | 0.040 |
Why?
|
Regional Blood Flow | 1 | 1983 | 1496 | 0.040 |
Why?
|
Cost Savings | 1 | 2005 | 913 | 0.040 |
Why?
|
Fetal Monitoring | 1 | 2019 | 69 | 0.040 |
Why?
|
Hepatectomy | 1 | 2002 | 557 | 0.040 |
Why?
|
Pan troglodytes | 1 | 2019 | 223 | 0.040 |
Why?
|
Mass Screening | 2 | 2011 | 5428 | 0.040 |
Why?
|
Physicians | 1 | 2016 | 4591 | 0.040 |
Why?
|
Follow-Up Studies | 3 | 2014 | 39106 | 0.040 |
Why?
|
Analysis of Variance | 1 | 2006 | 6228 | 0.040 |
Why?
|
Medicare | 1 | 2015 | 6770 | 0.040 |
Why?
|
Health Policy | 2 | 2015 | 2684 | 0.040 |
Why?
|
Blood Transfusion | 2 | 2017 | 1298 | 0.040 |
Why?
|
Hysterectomy, Vaginal | 1 | 2017 | 28 | 0.040 |
Why?
|
Infant, Premature | 2 | 2020 | 2107 | 0.040 |
Why?
|
Perfusion | 3 | 2008 | 1373 | 0.040 |
Why?
|
Interviews as Topic | 1 | 2024 | 2696 | 0.030 |
Why?
|
Uterine Artery Embolization | 1 | 2017 | 59 | 0.030 |
Why?
|
Medicaid | 1 | 2010 | 2818 | 0.030 |
Why?
|
Rh Isoimmunization | 1 | 2016 | 23 | 0.030 |
Why?
|
Physicians, Primary Care | 1 | 2023 | 623 | 0.030 |
Why?
|
Sex Chromosome Aberrations | 1 | 2016 | 116 | 0.030 |
Why?
|
Anthropometry | 1 | 2020 | 1349 | 0.030 |
Why?
|
Treatment Outcome | 4 | 2020 | 64680 | 0.030 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 2016 | 192 | 0.030 |
Why?
|
Internal Medicine | 1 | 2023 | 1051 | 0.030 |
Why?
|
Intraoperative Complications | 1 | 2002 | 1165 | 0.030 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2016 | 247 | 0.030 |
Why?
|
Diagnosis-Related Groups | 1 | 2017 | 449 | 0.030 |
Why?
|
Cell-Free System | 1 | 2016 | 340 | 0.030 |
Why?
|
Hydrops Fetalis | 1 | 2016 | 113 | 0.030 |
Why?
|
Salaries and Fringe Benefits | 1 | 2017 | 257 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2013 | 7407 | 0.030 |
Why?
|
False Negative Reactions | 1 | 2016 | 573 | 0.030 |
Why?
|
Mitochondria, Heart | 2 | 2008 | 229 | 0.030 |
Why?
|
Multiprotein Complexes | 1 | 2021 | 1118 | 0.030 |
Why?
|
Laparotomy | 1 | 2016 | 457 | 0.030 |
Why?
|
Genetics, Population | 1 | 2019 | 937 | 0.030 |
Why?
|
Liver Diseases | 1 | 2002 | 1298 | 0.030 |
Why?
|
Fetus | 1 | 2020 | 1863 | 0.030 |
Why?
|
Myocardium | 1 | 1986 | 4726 | 0.030 |
Why?
|
Organizational Policy | 1 | 2015 | 432 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2020 | 21012 | 0.030 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2017 | 513 | 0.030 |
Why?
|
Minority Groups | 1 | 2020 | 1203 | 0.030 |
Why?
|
Ultrasonography | 2 | 2020 | 5972 | 0.030 |
Why?
|
Hospital Costs | 1 | 2018 | 947 | 0.020 |
Why?
|
Gene Frequency | 1 | 2019 | 3606 | 0.020 |
Why?
|
Safety | 1 | 2016 | 1150 | 0.020 |
Why?
|
Patient Care Team | 1 | 2023 | 2521 | 0.020 |
Why?
|
Treatment Failure | 1 | 2018 | 2645 | 0.020 |
Why?
|
Rwanda | 1 | 2013 | 665 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2013 | 15631 | 0.020 |
Why?
|
Cesarean Section, Repeat | 1 | 2011 | 28 | 0.020 |
Why?
|
Fetal Organ Maturity | 1 | 2010 | 83 | 0.020 |
Why?
|
Infant | 3 | 2021 | 36192 | 0.020 |
Why?
|
Amniocentesis | 1 | 2010 | 115 | 0.020 |
Why?
|
Travel | 1 | 2016 | 796 | 0.020 |
Why?
|
Heart | 1 | 1983 | 4404 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2021 | 3113 | 0.020 |
Why?
|
Women | 1 | 2011 | 223 | 0.020 |
Why?
|
Rats | 2 | 2021 | 23742 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2011 | 17904 | 0.020 |
Why?
|
Adenosine Diphosphate | 2 | 2008 | 422 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2016 | 2358 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2017 | 14605 | 0.020 |
Why?
|
Protein Binding | 1 | 2021 | 9351 | 0.020 |
Why?
|
Rabbits | 2 | 1986 | 4772 | 0.020 |
Why?
|
Antibiotic Prophylaxis | 1 | 2013 | 636 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2019 | 5247 | 0.020 |
Why?
|
Citrate (si)-Synthase | 1 | 2008 | 48 | 0.020 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 2010 | 233 | 0.020 |
Why?
|
Cell Respiration | 1 | 2008 | 201 | 0.020 |
Why?
|
Family Planning Services | 1 | 2010 | 268 | 0.020 |
Why?
|
Male | 9 | 2023 | 360804 | 0.020 |
Why?
|
Indicator Dilution Techniques | 1 | 1986 | 43 | 0.020 |
Why?
|
Chemistry | 1 | 1986 | 347 | 0.020 |
Why?
|
Primary Health Care | 1 | 2023 | 4686 | 0.020 |
Why?
|
Infant, Premature, Diseases | 1 | 2012 | 710 | 0.020 |
Why?
|
Chemical Phenomena | 1 | 1986 | 507 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2020 | 12341 | 0.020 |
Why?
|
Insurance Coverage | 1 | 2017 | 1940 | 0.020 |
Why?
|
Cardiac Output | 1 | 2008 | 831 | 0.020 |
Why?
|
Recurrence | 1 | 2018 | 8465 | 0.020 |
Why?
|
Health Personnel | 1 | 2019 | 3335 | 0.020 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2012 | 846 | 0.020 |
Why?
|
Infant Mortality | 1 | 2010 | 759 | 0.020 |
Why?
|
Animals | 6 | 2021 | 168459 | 0.010 |
Why?
|
Models, Biological | 1 | 2021 | 9469 | 0.010 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2011 | 1351 | 0.010 |
Why?
|
Hospitalization | 2 | 2015 | 10723 | 0.010 |
Why?
|
Adenine Nucleotides | 1 | 1984 | 111 | 0.010 |
Why?
|
Rats, Wistar | 1 | 2008 | 1848 | 0.010 |
Why?
|
Sodium Chloride | 1 | 1986 | 587 | 0.010 |
Why?
|
Blood | 1 | 1986 | 596 | 0.010 |
Why?
|
Methods | 1 | 1983 | 1067 | 0.010 |
Why?
|
Tritium | 1 | 1983 | 708 | 0.010 |
Why?
|
Microspheres | 1 | 1986 | 784 | 0.010 |
Why?
|
Age of Onset | 1 | 2010 | 3305 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7390 | 0.010 |
Why?
|
Massachusetts | 1 | 2015 | 8830 | 0.010 |
Why?
|
Decision Making | 1 | 2015 | 3929 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 1 | 2010 | 1880 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 12947 | 0.010 |
Why?
|
Physical Examination | 1 | 2007 | 1255 | 0.010 |
Why?
|
Risk Reduction Behavior | 1 | 2007 | 1112 | 0.010 |
Why?
|
Serum Albumin | 1 | 1983 | 672 | 0.010 |
Why?
|
Plasma | 1 | 1983 | 586 | 0.010 |
Why?
|
NAD | 1 | 1984 | 614 | 0.010 |
Why?
|
Iodine Radioisotopes | 1 | 1983 | 1031 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 15936 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2011 | 3060 | 0.010 |
Why?
|
Length of Stay | 1 | 2012 | 6425 | 0.010 |
Why?
|
Aged | 4 | 2016 | 169289 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2015 | 22176 | 0.010 |
Why?
|
Perioperative Care | 1 | 2002 | 1033 | 0.010 |
Why?
|
Survival Analysis | 1 | 2007 | 10090 | 0.010 |
Why?
|
Mutation | 1 | 2019 | 30052 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2011 | 15842 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2007 | 58976 | 0.010 |
Why?
|
Coronary Disease | 1 | 1984 | 5914 | 0.010 |
Why?
|
Heart Failure | 1 | 2008 | 11669 | 0.000 |
Why?
|
Endocardium | 1 | 1984 | 248 | 0.000 |
Why?
|
Adenosine Monophosphate | 1 | 1984 | 231 | 0.000 |
Why?
|
Child, Preschool | 1 | 2002 | 42230 | 0.000 |
Why?
|
Dogs | 1 | 1984 | 3839 | 0.000 |
Why?
|
Adenosine Triphosphate | 1 | 1984 | 1989 | 0.000 |
Why?
|
Child | 1 | 2002 | 80153 | 0.000 |
Why?
|